MjLink Cannabis Business News and Press
After a three-year freeze on Oregon cannabis business license applications, the state has resumed the task this month.
The Oregon Liquor & Cannabis Commission (OLCC) originally hit the “pause” button on June 15, 2018, citing a backlog in paperwork and an oversupply of cannabis products in the market. At the time, concerns over diversion and out-of-state trafficking were emanating from the U.S. district attorney’s office.
It was unclear how long the pause would last—until this fall.
“Since [June 2018], the OLCC has made significant changes to streamline licensing and renewal processes that generally accelerates the licensing process,” according to a recently published state bulleting. “With these changes in place, the OLCC is now able to shift licensing staff back to processing new license applications.”
For those business who submitted retailer, wholesaler and processor applications on or after June 15, 2018, the state will be contacting applicants to get a sense of whether they are ready to move forward at this point.
Prospective cannabis growers, however, remain in a state of limbo for now. A law that invalidated all producer license applications submitted after June 15, 2018, is set to be repealed in January 2022. No new producer license applications are being accepted until then.
Colorado officials announced stricter rules for medical cannabis purchases Nov. 9 in an attempt to limit minors’ access, according to the Denver Post.
Mark Ferrandino, executive director of the Colorado Department of Revenue and a former speaker of the state’s House of Representatives, unveiled the new regulations, which were created with input from cannabis enforcement officials and a task force comprised of parents, health professionals and cannabis industry stakeholders, the news outlet reported.
Legislation passed earlier this year, House Bill 21-1317, established the task force to tighten Colorado’s cannabis laws to limit minors’ access to high-THC concentrates like shatter and wax, according to the Denver Post.
The new rules, which take effect Jan. 1, 2022, will limit the daily purchase of medical cannabis to 2 ounces of flower for all patients. Patients aged 21 and older will be able to purchase a maximum of 8 grams of cannabis concentrate per day, and the daily limit for younger medical patients between the ages of 18 and 20 will be 2 grams of concentrate per day, the Denver Post reported.
Dispensaries are required to enforce the new daily purchase limits by inputting the ID numbers found on patients’ medical cannabis cards, according to the news outlet. Sales must be refused to patients who seek to exceed their purchase limit.
The New Mexico Cannabis Control Division (CCD) recently announced that more than 1,500 prospective business owners have thrown their hats in the ring for an adult-use business license. The vast majority reportedly seek a microbusiness license, a cultivation tier that caps the number of plants at 200.
It’s an early sign of a business boom in New Mexico, which has no plans to limit the number of licenses that will be issued in this market. Similar to Oklahoma’s sprawling medical cannabis market, New Mexico regulators are taking a free-market approach to the licensing process.
“I don’t know that we could have anticipated what the demand was going to be other than knowing there really seems to be a great excitement across the state,” John Blair, deputy superintendent for the New Mexico Regulation and Licensing Department, told KRQE in a fairly expansive feature on the state of the industry in New Mexico right now. “If a million New Mexicans want to get a license, we would license a million people.”
Approval or rejection is meant to occur within 90 days of a submitted application.
Sales are expected to begin by April 1, giving the market a tight timeline right off the bat. And yet: Licensing is not yet on the table for retailers, transporters or product manufacturers; those rules need to be finalized by Jan. 1, according to the state law.
Aside from the short on-ramp ahead of adult-use sales, entrepreneurs are attuned to the high level of competition that is expected in this market. Applicant A.J. Sullins told the news station that his home state will likely follow the trends seen in other markets, where larger players spend freely to acquire small businesses and expand their footprint. “There’s going to be quite a few people who have received licensure and their costs are outweighing their revenue because they didn’t plan for a low-cost production. And they’re going to start to get consolidated or washed out within a three-year period,” he said.
VANCOUVER, British Columbia, November 15, 2021 - PRESS RELEASE - Village Farms International, Inc. (Village Farms) announced it has acquired 70% ownership of privately-held, Québec-based ROSE LifeScience (ROSE), a vertically integrated branded cannabis producer, supplier and commercialization expert in the Province of Québec. The transaction is valued at up to $46.7 million. ROSE becomes the Québec operational unit of Village Farms' Canadian cannabis business segment, with ROSE's headquarters and the existing team remaining in Québec.
ROSE is a third-party cannabis products commercialization expert in the Province of Québec, acting as the exclusive, direct-to-retail sales, marketing and distribution entity for Entourage Health, Sundial, Tilray and The Flowr Corporation and 10 Québec micro and craft growers throughout Québec. ROSE also distributes to Québec retail its brand of high-quality cannabis products. Tam Tams is grown and processed at ROSE's Québec-based, Health Canada-licensed 55,000-square-foot controlled environment agriculture (CEA), purpose-built facility in Huntingdon, which was commissioned in 2020. ROSE also enables a platform for commercialization in the market for several Québec-based micro-producers under its DLYS brand.
Highlights of the Acquisition
Adds a substantial presence in the Province of Québec as a cannabis supplier, producer and commercialization expert, which represents approximately 15% of total Canadian retail cannabis sales at the current annualized run rate of more than $627 million, the vast majority of which is dried flower and pre-rolled products;Adds experienced, Québec-based industry professionals who will join the Village Farms/Pure Sunfarms team, bolstering extensive existing relationships in the Québec cannabis market and leveraging specialized, deep experience in both consumer-packaged goods and regulated industries; and,Adds a Québec-based 55,000-square-foot, health Canada-licensed CEA cultivation and processing facility"The acquisition of ROSE, by far the most successful Québec-based cannabis operator in our view, is a prudent and strategic means by which to enter and rapidly ramp sales in one of Canada's largest provincial cannabis markets," said Michael DeGiglio, Village Farms CEO. "ROSE adds an exceptional group of Québec-based experts to our Canadian cannabis operations. The team has a proven track record of success, and shares our belief in the importance of cultivation excellence, as well as the advantage of innovation and continuous improvement. We look forward to building on ROSE's strong foundation in the Québec market, with a long-term commitment to the company's Québec heritage."
"ROSE immediately expands our reach to more than 90% of all Canadian retail cannabis sales and represents a major step forward in Pure Sunfarms' strategy to become the leading national supplier of cannabis in Canada, with at least a 20% market share in the dried flower category," said Mandesh Dosanjh, Pure Sunfarms president and CEO. "ROSE is very well respected in the Québec cannabis industry, with a reputation for leadership and brand strategy success that we have come to know well and respect. We look forward to pursuing the new opportunities, both near-term and long-term, created by the addition of ROSE as our Québec-based cannabis operational unit."
"We have long admired the success of Village Farms and Pure Sunfarms in the Canadian cannabis industry. We are proud to join forces with them to accelerate our successes and seize this opportunity to further evolve the industry in our home province of Québec," said Davide Zaffino, ROSE co-founder, president and CEO. "We cherish our Québec roots and deeply believe in our province's culture and values. As always, we remain committed to ensuring that Québec benefits from the responsible production, sale and consumption of cannabis. As part of the outstanding family of cannabis businesses within Village Farms, we are even better positioned to continue playing this leading role in the Québec landscape."
Jushi Holdings Inc., a multistate operator and owner of cannabis retail, cultivation and processing licenses based in Boca Raton, Fla., announced the opening of its 26th store nationwide and second BEYOND / HELLO retail location in Sterling, Va.
BEYOND / HELLO Sterling will serve and provide registered agents and medical cannabis patients "an efficient, accessible and safe experience that goes beyond the traditional cannabis retail environment," according to a recent press release.
Here, Brendon Lynch, Jushi executive vice president of retail, shares insight into the company's expansion and what consumers can expect, as well as offers a glimpse into Jushi's plan when adult-use sales go online in Virginia.
Andriana Ruscitto: Can you talk a little bit about Jushi's opening of its second BEYOND / HELLO retail location in Virginia and the different features the dispensary will have?
Brendon Lynch: So, we opened our second location in northern Virginia just last week, and the Virginia medical patients can expect a typical customer-centric BEYOND / HELLO retail experience, coupled with online ordering through beyond-hello.com and convenient in-store express pickup. Also, due to the rising demand, as well as improving accessibility for northern Virginia patients, we've expanded our delivery program to be in the Sterling location [and] the Manassas location.
The Sterling location operates out of an 8,000-square-foot anchor position in a newly constructed 16,000-square-foot building. [It] brings Virginia patients our suite of high-quality brands, including The Lab, Tasteology and, most recently, our two in-house flower brands: The Bank and Sèche.
In Texas, the back-and-forth legal debate over delta-8 THC has become quite the source of confusion, especially with the recent news that the Drug Enforcement Administration (DEA) has clarified that the compound is not a Schedule-I substance. What’s a hemp product manufacturer to do in Texas?
This week, Veterans Day threw the issue into stark relief.
“There are a lot of veterans in Texas, and veterans are consistently the people that respond to us saying, ‘Hey, these products are amazing. They've changed my life. They allow me to go outside without anxiety and other stuff, they help with our PTSD,’” Hometown Hero CEO Lukas Gilkey told the Austin American-Statesman. “Almost every single one of the testimonials we receive references somebody's cancer, their chemotherapy, their sleeping issues, their eating issues or their PTSD.”
This has been a consistent point of contention all year, with hemp businesses in many U.S. states finding little choice in the matter. Demand for delta-8 THC products is so great, it would be difficult not to get into the market.
And yet. In an industry as tightly regulated as hemp—to say nothing of state-licensed cannabis landscape—no one wants to run afoul of the law, even if it’s changing from day to day.
We’ve rounded up some of the key cannabis headlines from the week right here.
A Republican-sponsored medical cannabis expansion bill in Ohio intends to give licensed physicians the power to determine qualifying conditions on a case-by-case basis.
State Sen. Steve Huffman, who represents a Dayton-area district in Southwest Ohio, introduced Senate Bill 261 Nov. 9.
While the 66-page legislation would expand the list of qualifying conditions for medical cannabis to include autism spectrum disorder, arthritis, migraines and terminal illness, it ultimately would include “any other medical condition” determined by a licensed physician.
Since the inception of Ohio’s medical cannabis program in 2016, and its implementation in 2019, Huffman has worked alongside medical providers, the state’s Board of Pharmacy and the Department of Commerce to identify ways to improve the program to better serve patients, according to a news release from his office.
“As a medical doctor and a state senator, I am committed to the quality of life of the people I serve,” Huffman said in the release. “The provisions in this bill are about improving the treatment options for patients.”
The bill would allow for medical cannabis to be processed and dispensed in additional forms so that a patient can be treated through a variety of methods. Curbside and drive-thru dispensing, which Ohio and many other states OK’d as COVID-19 safety measures, would be continued.
Adult-use cannabis sales are one step closer to becoming a reality in New Jersey.
After the New Jersey Cannabis Regulatory Commission (CRC) missed its deadline to start accepting business license applications in September, the commission has finally announced applications for growers, producers and testing laboratories will open Dec. 15. Adult-use license applications for retailers will open March 15, 2022, and applications will be accepted on a rolling basis, NJ.com reported.
According to JD Supra, CRC will prioritize reviewing, scoring and approving applications in the following order:
Social Equity Businesses ApplicantsDiversely Owned Businesses ApplicantsImpact Zone Businesses ApplicantsLicense Applicants receiving bonus points for collective bargaining agreements, project labor agreements or residencyAll other applicantsAdditionally, “priority will be given to conditional license applications over annual license applications, and microbusiness applications will be prioritized over standard cannabis business applications in every category,” the article states.
As Cannabis Business Times previously reported, the CRC is not permitted to approve more than 37 cultivation licenses between February 2021 and February 2023—excluding microbusinesses and expanded alternative treatment centers. However, during that time, the CRC may accept and review additional licenses as long as the issued license number does not exceed 37.
Looking Ahead
MIAMI, Florida, November 12, 2021 — PRESS RELEASE — Ayr Wellness Inc. (Ayr), a vertically integrated cannabis multistate operator (MSO), announced the opening of Ayr Wellness Montgomeryville, the company's seventh affiliated dispensary operating in the commonwealth of Pennsylvania.
"We continue to appreciate the warm reception that we've received from Pennsylvania's patient community, a particularly discerning group with a keen understanding of quality," said Jonathan Sandelman, Ayr founder, chairman and CEO. "We consistently strive to deliver the best quality product at an accessible price. And now, with a seven-store footprint and robust wholesale operation, we look forward to introducing more Pennsylvania patients to the Ayr way."
The Montgomeryville dispensary is located at the "Five Points" junction, a popular shopping area in Montgomeryville, Pa. The 8,400-square-foot store continues the rapid expansion of the Ayr organization's presence in Pennsylvania's burgeoning medical cannabis market.
Montgomeryville is a northern suburb of Philadelphia, located in Montgomery County, the third most populous county in Pennsylvania, with over 850,000 residents according to the 2020 Census.
The new location features a curated selection of high-quality medical cannabis products, including Ayr-owned brands, Origyn Extracts, Seven Hills flower and Revel flower, and products sourced from third-party brands throughout the state. The store has 12 point of sale (POS) stations and 46 parking spaces.
Pennsylvania has a robust and growing medical cannabis market with over 633,000 patients, 132 licensed dispensaries and 29 operational licensed cultivators and processors. Annual industry-wide statewide cannabis sales in Pennsylvania are expected to surpass $1 billion by 2024, according to BDSA.
LAS VEGAS, Nevada, November 10, 2021 - PRESS RELEASE - Terry Booth, CEO of Australis Capital Inc. (AUDACIOUS), an emerging global cannabis company with an expanding suite of multistate operations, is delighted to announce the company's majority-owned subsidiary, ALPS, has entered into a partnership agreement with Priva. Priva is a technology company in the development and sales of hardware, software, and data services in climate control, energy-saving and optimal water reuse. The partnership will focus on the joint marketing of ALPS' advanced compliance and maintenance service solution, APIS, across the global horticulture industry.
Priva is a global supplier in environmental climate solutions for the horticulture sector, offering sustainable solutions that optimize climate control and yield savings in energy and water utilization. Priva operates 16 offices globally, has a presence in over 100 countries and a substantial installed customer base of over 12,000 projects. With this strong foundation, the partnership between ALPS and Priva is well positioned to introduce the new APIS solution to a captive audience.
Compliance and risk reduction are increasingly becoming standard requirements for the horticultural industry. Increasingly, expectations and demands regarding the security of supply, while achieving optimal quality and efficiency, are getting stricter. Both companies believe they are well positioned to enhance solutions and operational protocols in food security, safety and compliance. Technology and innovation, core competencies for both companies, are essential to drive future success in the emerging field of industrial greenhouse management.
The ALPS team of specialists created the APIS system to provide a highly advanced, industrial-level compliance and (predictive) maintenance service solution specifically focusing on greenhouses and other indoor controlled environment agriculture operations. APIS consists of a suite of tools and services designed to help achieve good manufacturing practices (GMP) compliance and significantly improve maintenance effectiveness, efficiencies, yield and predictive modeling. APIS integrates with multiple greenhouse sub-systems and processes to deliver significant overall process improvements, generating significant and sustainable ROI for operators.
"Partnering with Priva will be transformational for our business as it significantly expands our market reach," said Thomas Larssen, ALPS president. "Like us, Priva is an integral part of the horticulture industry, is incredibly well respected, and has a global reach that is difficult to match. Partnering with Priva offers a significant opportunity for AUDACIOUS to accelerate the commercial rollout of its APIS system. This is a strong endorsement of the standing of and hard work by the ALPS team by the global leader in their field. We believe this partnership should contribute to strong revenue growth for ALPS and AUDACIOUS."
"Rather than adapt and use existing systems from varying industries and suppliers with no roots in our sector, we opted to build our APIS solution ourselves from the ground up," Larssen added. "APIS meets the needs of today, while ensuring operations are future proof. This truly is a system of the industry, by the industry and for the industry, and that's why interest is so high."
CHICAGO, Nov. 10, 2021 (GLOBE NEWSWIRE) -- PRESS RELEASE -- Verano Holdings Corp., a multi-state cannabis company, today announced it has entered into multiple agreements to acquire all of the issued and outstanding equity interests of Caring Nature, LLC and Connecticut Pharmaceutical Solutions, Inc., along with the closing of its acquisition of Willow Brook Wellness, LLC.
Caring Nature owns an active dispensary in Waterbury, Conn.; Connecticut Pharmaceutical Solutions owns an operating cultivation and production facility in Rocky Hill, Conn.; and Willow Brook Wellness holds an active dispensary in Meriden, Conn. Collectively, these acquisitions expand Verano’s presence on the East Coast with the addition of vertically integrated operations in the attractive Connecticut market.
RELATED: A Key Piece to the Puzzle: Verano Holdings CEO George Archos Discusses AltMed Merger
“We are excited about the continued expansion of both our national platform and our East Coast hub. Entering the Connecticut market ahead of its adult-use transition provides a clear runway for sustainable, long-term growth,” said George Archos, Verano's founder and chief executive officer. “These acquisitions are well-aligned with our broader growth strategy, and further strengthen our operational bandwidth by bringing management teams on board that have demonstrated multi-disciplinary savvy and a keen understanding of the Connecticut market in both the retail and wholesale channels.”
Transaction Highlights
Willow Brook Wellness, LLC
A Texas judge has barred the state from listing delta-8 THC as a Schedule I drug, meaning that the cannabis compound is legal in Texas again under the temporary injunction.
Last month, the Texas Department of State Health Services (DSHS) added a statement to its website declaring delta-8 illegal under state law.
“Texas Health and Safety Code Chapter 443 (HSC 443), established by House Bill 1325 (86th Legislature), allows Consumable Hemp Products in Texas that do not exceed 0.3% Delta-9 tetrahydrocannabinol (THC),” the website reads. “All other forms of THC, including Delta-8 in any concentration and Delta-9 exceeding 0.3%, are considered Schedule I controlled substances.”
Until last month, businesses have sold products containing delta-8 THC under what they perceived as a grey area of H.B. 1325, which Gov. Greg Abbott signed into law in 2019 to legalize the cultivation of hemp that contains less than 0.3% delta-9 THC. Since the law did not specifically address delta-8, manufacturers ramped up the production of delta-8 products under the assumption that they were legal, until the DSHS clarified its stance that delta-8 is a Schedule I controlled substance.
Austin-based Sky Marketing Corp., which does business as Hometown Hero, filed a lawsuit in Travis County district court shortly after DSHS released its statement on delta-8 THC, seeking to block the department from taking “enforcement action” against the sale of products containing the compound, which the store owner argues are legal under both federal and state law.
Most Americans can’t agree on the pronunciation of “Jif” peanut butter, whether hotdogs are sandwiches and if pro wrestling should be considered a sport, according to American comedian and actress Sarah Silverman.
“Fortunately, there’s at least one thing most Americans have in common,” she said Nov. 9 during an 80-second video to help kick-start the “Cannabis in Common” initiative, a campaign to encourage the American electorate to speak up in favor of advancing federal cannabis legalization in the U.S. Congress.
More than two-thirds of Americans agree that cannabis should be legalized, Silverman said, yet broad reform efforts haven’t picked up steam in the U.S. Senate. According to a 2021 poll from Quinnipiac University, 69% of Americans support legalizing cannabis.
In a separate video also released Tuesday, Canadian actor and comedian Seth Rogen reiterated that the overwhelming majority of Americans support legalization.
“Despite what you may have heard, Americans can actually agree on something,” he said. “And that something is weed.”
The celebrity duo has joined forces to help launch the Cannabis in Common initiative in coordination with reform organization U.S. Cannabis Council (USCC) and HeadCount’s Cannabis Voter Project.
November 4, 2021 – PRESS RELEASE – Canapa has introduced the JuanaOne, the latest addition to its family of pre-roll machines.
The JuanaOne is engineered as a work center where a single person can weigh, fill and compact up to 500 joints per hour in less than 5 square feet of floor space.
Using the same mechanical design as its sister, the JuanaRoll, the JuanaOne includes a bulk canister, a weight cell to ensure accurate weight measurement and a unique compaction system to ensure consistent, compacted joints.
This automated pre-roll solution is perfect for LPs that want to avoid volumetric filling and convert to accurate weighing as well as those that need more productivity, have limited space or require multiple changeovers.
The JuanaOne pre-roll machine is built using 304 stainless steel, making it easy to clean, and its user-friendly HMI and on-screen production statistics allow real-time reporting at the touch of a button.
Shryne Group has tapped Cary Berger as its Chief Legal Officer.
In his new role, Berger will be lead the company's legal functions and advise the board and management on all business, legal, and policy matters, according to Shryne Group. He will report to Shryne Group CEO Jon Avidor.
"Cary is that rare person who understands both the intricacies of cannabis law and more traditional corporate law and governance," Avidor says. "His experience and leadership will be crucial as we continue to expand both in California and in new states."
Berger joins Shryne Group after previously serving as general counsel and chief administrative office for Houseplant, Seth Rogen and Evan Goldberg's cannabis company.
"Throughout my career, I have worked with private and public companies at the brink of massive growth, and that's certainly the opportunity I see for Shryne," Berger says. "I'm excited to help Shryne navigate its next era."
]]>South Dakota is now taking applications for medical cannabis cards as physicians begin certifying patients for the program, according to a KELO report.
Physicians can now access the state’s medical cannabis patient portal to certify patients, according to an update on the program’s website. Patients with a “debilitating medical condition” can qualify for medical cannabis, according to KELO.
Once a patient receives certification from a physician, he or she can access the online application process to obtain a medical cannabis ID card.
South Dakota lawmakers approved the state's medical cannabis regulations last month, and the Department of Health was required to begin issuing medical cannabis ID cards by Nov. 18 under Measure 26, South Dakota’s voter-approved medical cannabis legalization measure.
Meanwhile, the South Dakota Supreme Court is expected to issue a ruling on the constitutionality of Amendment A, the state’s voter-approved adult-use legalization measure that has been challenged in court.
Viola Brands launched in Canada through a partnership with Avicanna Inc., a Canadian biopharmaceutical company headquartered in Toronto.
Avicanna is responsible for managing overall commercialization of all Viola products in Canada through its manufacturing, distribution, and sales infrastructure, according to a company statement. Viola products are currently available on Medical Cannabis by Shoppers, an digital platform and subsidiary of Shoppers Drug Mart Inc.
Michigan-based Viola, founded in 2011 by 16-year NBA veteran Al Harrington, currently has a licensed footprint in five states, in addition to its production expansion to Canada.
"We're excited to launch in Canada with our partner, Avicanna, who shares our vision to increase representation and promote equity within the cannabis industry," said Harrington, co-founder and CEO of Viola, in a press release. "And look forward to having Viola's premium products available at Medical Cannabis by Shoppers."
Viola products currently available through Medical Cannabis by Shoppers include THC and CBD products, including cartridges, concentrates, and disposable vaporizers.
NEW YORK, Nov. 8, 2021 – PRESS RELEASE – Columbia Care Inc., one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S., announced that it has opened a third dispensary at 11190 West Broad St., in Glen Allen, Va., under the gLeaf brand.
“We are pleased to be able to serve the greater Richmond metropolitan area, especially on the heels of the recent addition of whole flower to our product offerings,” Columbia Care CEO Nicholas Vita said. “This dispensary opening marks the next step in our expansion in Virginia to help support the rapidly expanding medical program and its more than 33,000 patients. We are thankful for the support from the Board of Pharmacy and local officials as we continue to grow and evolve.”
In the coming months, the company will open two more locations in Carytown and Virginia Beach. Columbia Care and gLeaf are actively developing seven additional dispensaries for a total of 12. Columbia Care is also in the process of rebranding its Portsmouth location as Cannabist, bringing an elevated patient experience to the Hampton Roads area. The company operates 147,765 square feet of cultivation and production space across Virginia, including its 82,000-square-foot indoor cultivation facility, the largest in the commonwealth.
The new dispensary includes two drive-thru windows and 12 registers. It will carry gLeaf and Seed & Strain brands, and expects to launch Triple Seven, Classix and other brands, pending regulatory approval. The store is open 9 a.m.-8 p.m. Monday through Saturday and 9 a.m.-7 p.m. on Sunday.
For more information, please visit gleaf.com.
]]>TALLAHASSEE, Fla., Nov. 8, 2021 – PRESS RELEASE – Trulieve Cannabis Corp., the largest multistate operator (MSO) in the U.S., announced the opening of its first dispensary in West Virginia. Trulieve Morgantown, located at 1397 Earl Core Road, will be the first dispensary in the state to sell medical cannabis. Trulieve will host a ribbon cutting and open its doors to patients at the Morgantown dispensary on Friday, Nov. 12. The company also plans to open its second retail location in Weston, located at 137 Staunton Drive, on Monday, Nov. 15.
West Virginia registered, age-verified patients with a valid medical cannabis card can access Trulieve's diverse product line, including TruFlower, TruClear concentrates, TruSpectrum Whole Plant Extract and Botanical TruPOD cartridges, in addition to a selection of Momenta topicals, capsules and tinctures.
Trulieve invites the Morgantown community to join in celebrating the opening of its first West Virginia dispensary. As part of the festivities, patients will receive a 25% in-store discount on opening day and can enjoy free swag giveaways, music, and complimentary food from neighboring Pizza Al's. Those who are not yet registered patients can receive assistance onsite to complete a patient card application on opening day. Trulieve Morgantown will be open from 10 a.m.-6 p.m. Thursday through Saturday, and Trulieve Weston will be open from 10 a.m.-6 p.m. on Monday and Tuesday.
ANNOUNCING: Trulieve Morgantown Ribbon Cutting and Dispensary Opening
WHERE: 1397 Earl Core Rd. Morgantown, WV 26505
WHEN: Friday, Nov. 12, 2021, at 9:45 a.m.
ANNOUNCING: Trulieve Weston Dispensary Opening
WHERE: 137 Staunton Dr. Weston, WV 26452
WHEN: Monday, Nov. 15, 2021, at 10 a.m.
"We're thrilled to be first to market in West Virginia and to continue building the foundation for the West Virginia's emerging medical cannabis market," Trulieve CEO Kim Rivers said. "Our team is especially eager to leverage our first-mover advantage to bolster local economies by creating sustainable jobs and investing in marginalized communities. We look forward to serving West Virginia patients, who have been patiently waiting for this day to arrive, with an unparalleled retail experience and the high-quality medical cannabis products they can rely on for safe and effective relief."
EDMONTON,Alberta, Nov. 8, 2021 – PRESS RELEASE – Aurora Cannabis Inc., a Canadian company focusedon defining the future of cannabinoids worldwide, announced that AuroraNederland B.V., a wholly owned indirect subsidiary of the company, has enteredinto an agreement to invest in a significant equity stakein Netherlands-based Growery B.V., one of the few license holders entitledto participate in the controlled cannabis supply chain (CCSC) experiment. Theagreement is subject to the regulatory notification procedure.
Aurora'sinvestment in Growery is structured such that the company intends to invest animmaterial cash amount of which a portion is due and payable upfront, and theremainder dependent on Growery achieving certainmilestones. Under the terms, Aurora will provide a secured loan toGrowery to construct a facility, fund early operations and provide technicaland operational support through its Netherlands-based, state-of-the-artresearch facility for medical cannabis, established in 2018. Aurora expects tofully consolidate the revenues realized through the investment into Growery underthe applicable International Financial Reporting Standards.
"Ourinvestment in Growery is a significant advancement for our global recreationalcannabis strategy,” Aurora CEO Miguel Martin said. “The Netherlands is expectedto be the largest federally regulated recreational market outside of Canada andis a proof point that our medical market success in Europe is portable torecreational markets. Aurora's global leadership is underscored by a proventrack record of regulatory compliance, testing and commitment to science. Withsimilar values and commitment to excellence, we are pleased to be working withGrowery to enter the Dutch market."
TheCCSC is scheduled to be in effect for a minimum of four years, during which theDutch government will evaluate if the rules of the CCSC should be expandednationally. Anticipated demand during the CCSC is approximately 30,000kilograms of dried flower annually. Should the CCSC be expanded nationally(from approximately 80 coffee shops in 10 selected municipalities to the nearly600 coffee shops that exist today), it is estimated that the Netherlands wouldrequire approximately 200,000 kilograms of dried flower annually to fulfilldemand.
]]>